Publication | Closed Access
Nucleic Acid Related Compounds. 116. Nonaqueous Diazotization of Aminopurine Nucleosides. Mechanistic Considerations and Efficient Procedures with <i>tert-</i>Butyl Nitrite or Sodium Nitrite<sup>,</sup><sup>1</sup>
45
Citations
27
References
2002
Year
Bioorganic ChemistryMolecular BiologyNucleic Acid Amplification TestPurine Radical SpeciesOrganic ChemistryChemistryMechanistic ConsiderationsChemical BiologyHeterocycle ChemistryNucleic Acid BiomarkersNucleic Acid ChemistryAminopurine NucleosidesNonaqueous Diazotization-dediazoniationBiochemistryOligonucleotideNonaqueous DiazotizationPharmacologyEnantioselective SynthesisNatural SciencesDiazotization ReagentNucleic Acid BiochemistryNucleic Acid AmplificationHalogenationDerivative (Chemistry)Synthetic Chemistry
Nonaqueous diazotization-dediazoniation of two types of aminopurine nucleoside derivatives has been investigated. Treatment of 9-(2,3,5-tri-O-acetyl-beta-D-ribofuranosyl)-2-amino-6-chloropurine (1) with SbCl(3)/CH(2)Cl(2) was examined with benzyltriethylammonium (BTEA) chloride as a soluble halide source and tert-butyl nitrite (TBN) or sodium nitrite as the diazotization reagent. Optimized yields (>80%) of the 2,6-dichloropurine derivative were obtained with SbCl(3). Combinations with SbBr(3)/CH(2)Br(2) gave the 2-bromo-6-chloropurine product (>60%), and SbI(3)/CH(2)I(2)/THF gave the 2-iodo-6-chloropurine derivative (>45%). Antimony trihalide catalysis was highly beneficial. Mixed combinations (SbX(3)/CH(2)X'(2); X/X' = Br/Cl) gave mixtures of 2-(bromo, chloro, and hydro)-6-chloropurine derivatives that were dependent on reaction conditions. Addition of iodoacetic acid (IAA) resulted in diversion of purine radical species into a 2-iodo-6-chloropurine derivative with commensurate loss of other radical-derived products. This allowed evaluation of the efficiency of SbX(3)-promoted cation-derived dediazoniations relative to radical-derived reactions. Efficient conversions of adenosine, 2'-deoxyadenosine, and related adenine nucleosides into 6-halopurine derivatives of current interest were developed with analogous combinations.
| Year | Citations | |
|---|---|---|
Page 1
Page 1